Inhibition of tumor formation and redirected differentiation of glioblastoma cells in a xenotypic embryonic environment

Developmental Dynamics

Volumn 242, Issue 9, 2013, Pages 1078-1093

  Joel, Mrinal ^a,b   Sandberg, Cecilie J ^b   Boulland, Jean Luc ^a,b   Vik Mo, Einar O ^b   Langmoen, Iver A ^b   Glover, Joel C ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Chicken embryo; Glioblastoma; Glioma; PTEN; Tumor reprogramming

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHORIOALLANTOIS; EMBRYO; EMBRYONAL TISSUE; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NERVOUS TISSUE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SCID MOUSE; TUMOR MICROENVIRONMENT; ANIMAL; CELL LINE; CHICK EMBRYO; CLINICAL TRIAL; CYTOLOGY; EMBRYOLOGY; FEMALE; MALE; METABOLISM; NEURAL TUBE; PATHOLOGY; PHYSIOLOGY; XENOGRAFT;

MUS;

ANIMALS; CELL LINE; CELLULAR MICROENVIRONMENT; CHICK EMBRYO; FEMALE; GLIOBLASTOMA; HETEROGRAFTS; HUMANS; MALE; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NERVE TISSUE; NEURAL TUBE;

EID: 84882615415     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.24001     Document Type: Article

References (56)

1. Boulland JL, Halasi G, Kasumacic N, Glover JC. 2010. Xenotransplantation of human stem cells into the chicken embryo. J Vis Exp pii:2071.
2. Boulland JL, Leung DS, Thuen M, Vik-Mo E, Joel M, Perreault MC, Langmoen IA, Haraldseth O, Glover JC. 2012. Evaluation of intracellular labeling with micron-sized particles of iron oxide (MPIOs) as a general tool for in vitro and in vivo tracking of human stem and progenitor cells. Cell Transplant 21:1743-1759.
3. Campos B, Wan F, Farhadi M, Ernst A, Zeppernick F, Tagscherer KE, Ahmadi R, Lohr J, Dictus C, Gdynia G, Combs SE, Goidts V, Helmke BM, Eckstein V, Roth W, Beckhove P, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende C. 2010. Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res 16:2715-2728.
4. Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ, Loeffler JS. 2002. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 20:1063-1068.
5. Chen H, Shen X, Guo C, Zhu H, Zhou L, Zhu Y, Wang H, Zheng Y, Huang L. 2010. Phosphatase and tensin homolog reconstruction and vascular endothelial growth factor knockdown synergistically inhibit the growth of glioblastoma. Cancer Biother Radiopharm 25:713-721.
6. Clarke DL, Johansson CB, Wilbertz J, Veress B, Nilsson E, Karlstrom H, Lendahl U, Frisen J. 2000. Generalized potential of adult neural stem cells. Science 288:1660-1663.
7. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM. 2006. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66:9339-9344.
8. Das A, Tan WL, Teo J, Smith DR. 2002. Expression of survivin in primary glioblastomas. J Cancer Res Clin Oncol 128:302-306.
9. Dasari VR, Kaur K, Velpula KK, Gujrati M, Fassett D, Klopfenstein JD, Dinh DH, Rao JS. 2010. Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway. PLoS One 5:e10350.
10. Diez-Torre A, Andrade R, Eguizabal C, Lopez E, Arluzea J, Silio M, Arechaga J. 2009. Reprogramming of melanoma cells by embryonic microenvironments. Int J Dev Biol 53:1563-1568.
11. Dolberg DS, Bissell MJ. 1984. Inability of Rous sarcoma virus to cause sarcomas in the avian embryo. Nature 309:552-556.
12. Drago J, Murphy M, Carroll SM, Harvey RP, Bartlett PF. 1991. Fibroblast growth factor-mediated proliferation of central nervous system precursors depends on endogenous production of insulin-like growth factor I. Proc Natl Acad Sci U S A 88:2199-2203.
13. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F, Vescovi A. 2004. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64:7011-7021.
14. Gerschenson M, Graves K, Carson SD, Wells RS, Pierce GB. 1986. Regulation of melanoma by the embryonic skin. Proc Natl Acad Sci U S A 83:7307-7310.
15. Goldstein RS, Drukker M, Reubinoff BE, Benvenisty N. 2002. Integration and differentiation of human embryonic stem cells transplanted to the chick embryo. Dev Dyn 225:80-86.
16. Gunther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S, Soriano R, Modrusan Z, Meissner H, Westphal M, Lamszus K. 2008. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 27:2897-2909.
17. Hart I. 1997. Germ cell tumors. In: Tumors of the fetus and newborn. Philadelphia, PA: WB Saunders.
18. Halasi G, Soviknes AM, Sigurjonsson O, Glover JC. 2012. Proliferation and recapitulation of developmental patterning associated with regulative regeneration of the spinal cord neural tube. Dev Biol 365:118-132.
19. Hamburger V, Hamilton HL. 1992. A series of normal stages in the development of the chick embryo. 1951. Dev Dyn 195:231-272.
20. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
21. Heddleston JM, Hitomi M, Venere M, Flavahan WA, Yang K, Kim Y, Minhas S, Rich JN, Hjelmeland AB. 2011. Glioma stem cell maintenance: the role of the microenvironment. Curr Pharm Des 17:2386-2401.
22. Helseth R, Helseth E, Johannesen TB, Langberg CW, Lote K, Ronning P, Scheie D, Vik A, Meling TR. 2010. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta Neurol Scand 122:159-167.
23. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, Kornblum HI. 2003. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 100:15178-15183.
24. Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J, Kulesa PM, Postovit LM. 2007. Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer 7:246-255.
25. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. 2002. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39:193-206.
26. James CD, Olson JJ. 1996. Molecular genetics and molecular biology advances in brain tumors. Curr Opin Oncol 8:188-195.
27. Kajiwara Y, Yamasaki F, Hama S, Yahara K, Yoshioka H, Sugiyama K, Arita K, Kurisu K. 2003. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Cancer 97:1077-1083.
28. Kleihus P, Cavenee WK. 2000. Pathology and genetics: tumors of the nervous system. Lyon, France.
29. Koul D. 2008. PTEN signaling pathways in glioblastoma. Cancer Biol Ther 7:1321-1325.
30. Kulesa PM, Kasemeier-Kulesa JC, Teddy JM, Margaryan NV, Seftor EA, Seftor RE, Hendrix MJ. 2006. Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. Proc Natl Acad Sci U S A 103:3752-3757.
31. Mbeunkui F, Johann DJ Jr. 2009. Cancer and the tumor microenvironment: a review of an essential relationship. Cancer Chemother Pharmacol 63:571-582.
32. Mintz B, Illmensee K. 1975. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci U S A 72:3585-3589.
33. Ohgaki H, Kleihues P. 2009. Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci 100:2235-2241.
34. Olstorn H, Moe MC, Roste GK, Bueters T, Langmoen IA. 2007. Transplantation of stem cells from the adult human brain to the adult rat brain. Neurosurgery 60:1089-1098; discussion 1098-1099.
35. Ozawa T, Brennan CW, Wang L, Squatrito M, Sasayama T, Nakada M, Huse JT, Pedraza A, Utsuki S, Yasui Y, Tandon A, Fomchenko EI, Oka H, Levine RL, Fujii K, Ladanyi M, Holland EC. 2010. PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas. Genes Dev 24:2205-2218.
36. Paget S. 1889. The distribution of secondry growths in cancer of the breast. Lancet 1:571-573.
37. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, Brem H, Olivi A, Dimeco F, Vescovi AL. 2006. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444:761-765.
38. Pierce GB, Pantazis CG, Caldwell JE, Wells RS. 1982. Specificity of the control of tumor formation by the blastocyst. Cancer Res 42:1082-1087.
39. Pisati F, Belicchi M, Acerbi F, Marchesi C, Giussani C, Gavina M, Javerzat S, Hagedorn M, Carrabba G, Lucini V, Gaini SM, Bresolin N, Bello L, Bikfalvi A, Torrente Y. 2007. Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models. Cancer Res 67:3054-3063.
40. Podesta AH, Mullins J, Pierce GB, Wells RS. 1984. The neurula stage mouse embryo in control of neuroblastoma. Proc Natl Acad Sci U S A 81:7608-7611.
41. Postovit LM, Margaryan NV, Seftor EA, Kirschmann DA, Lipavsky A, Wheaton WW, Abbott DE, Seftor RE, Hendrix MJ. 2008. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci U S A 105:4329-4334.
42. Ralphs JR, Wylie L, Hill DJ. 1990. Distribution of insulin-like growth factor peptides in the developing chick embryo. Development 109:51-58.
43. Ruiz i Altaba A. 2011. Hedgehog signaling and the Gli code in stem cells, cancer, and metastases. Sci Signal 4:pt9.
44. Sigurjonsson OE, Perreault MC, Egeland T, Glover JC. 2005. Adult human hematopoietic stem cells produce neurons efficiently in the regenerating chicken embryo spinal cord. Proc Natl Acad Sci U S A 102:5227-5232.
45. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB. 2003. Identification of a cancer stem cell in human brain tumors. Cancer research 63:5821-5828.
46. Strojnik T, Kavalar R, Barone TA, Plunkett RJ. 2010. Experimental model and immunohistochemical comparison of U87 human glioblastoma cell xenografts on the chicken chorioallantoic membrane and in rat brains. Anticancer Res 30:4851-4860.
47. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO. 2009. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459-466.
48. Tamguney T, Stokoe D. 2007. New insights into PTEN. J Cell Sci 120:4071-4079.
49. Varghese M, Olstorn H, Sandberg C, Vik-Mo EO, Noordhuis P, Nister M, Berg-Johnsen J, Moe MC, Langmoen IA. 2008. A comparison between stem cells from the adult human brain and from brain tumors. Neurosurgery 63:1022-1033; discussion 1033-1034.
50. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN, Cancer Genome Atlas Research Network. 2010. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98-110.
51. Vik-Mo EO, Sandberg C, Olstorn H, Varghese M, Brandal P, Ramm-Pettersen J, Murrell W, Langmoen IA. 2010. Brain tumor stem cells maintain overall phenotype and tumorigenicity after in vitro culturing in serum-free conditions. Neuro Oncol 12:1220-1230.
52. Vik-Mo EO, Sandberg C, Joel M, Stangeland B, Watanabe Y, Mackay-Sim A, Moe MC, Murrell W, Langmoen IA. 2011. A comparative study of the structural organization of spheres derived from the adult human subventricular zone and glioblastoma biopsies. Exp Cell Res 317:1049-1059.
53. Woodward PJ, Sohaey R, Kennedy A, Koeller KK. 2005. From the archives of the AFIP: a comprehensive review of fetal tumors with pathologic correlation. Radiographics 25:215-242.
54. Yuan X, Curtin J, Xiong Y, Liu G, Waschsmann-Hogiu S, Farkas DL, Black KL, Yu JS. 2004. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23:9392-9400.
55. Zbinden M, Duquet A, Lorente-Trigos A, Ngwabyt SN, Borges I, Ruiz i Altaba A. 2010. NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. EMBO J 29:2659-2674.
56. Zhou BB, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB. 2009. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 8:806-823.